¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T45"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
2
ÄÚµå
¿µ¹®
ÇѱÛ
T45.6
Fibrinolysis-affecting drugs
¼¶À¯¼Ò ¿ëÇØ¼º ¾à¹°
T45.4
Iron and its compounds
ö ¹× ±× º¹ÇÕ¹°
T45.8
Other primarily systemic and haematological agents
±âŸ ÀÏÂ÷ÀûÀ¸·Î Àü½Å ¹× Ç÷¾×ÇÐÀû ¾à¹°
T45
Poisoning by primarily systemic and haematological agents, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Àü½Å ¹× Ç÷¾×¿¡ ÀÏÂ÷ÀûÀ¸·Î ÀÛ¿ëÇÏ´Â ¾à¹°¿¡ ÀÇÇÑ Áßµ¶
T45.9
Primarily systemic and haematological agent, unspecified
»ó¼¼ºÒ¸íÀÇ ÀÏÂ÷ÀûÀ¸·Î Àü½Å ¹× Ç÷¾×ÇÐÀû ¾à¹°
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½